COEP Coeptis Therapeutics Holdings Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: COEP

Price (delayed)

$0.37

Market cap

$13.35M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.83

Enterprise value

$13.11M

Highlights
Coeptis Therapeutics Holdings's debt has decreased by 40% YoY and by 9% from the previous quarter
The EPS has soared by 68% YoY but it has decreased by 9% QoQ
COEP's net income is up by 43% YoY but it is down by 4% from the previous quarter
The quick ratio has declined by 5% since the previous quarter and by 5% year-on-year
The equity is down by 3.1% year-on-year
Sector: Healthcare
Industry: Biotechnology
Peers: TRAW

Key stats

What are the main financial stats of COEP
Market
Shares outstanding
36.09M
Market cap
$13.35M
Enterprise value
$13.11M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.93
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$21.16M
EBITDA
-$20.16M
Free cash flow
-$7.24M
Per share
EPS
-$0.83
Free cash flow per share
-$0.28
Book value per share
$0.13
Revenue per share
$0
TBVPS
$0.31
Balance sheet
Total assets
$8.07M
Total liabilities
$3.76M
Debt
$1.22M
Equity
$4.31M
Working capital
$2.26M
Liquidity
Debt to equity
0.28
Current ratio
1.76
Quick ratio
1.66
Net debt/EBITDA
0.01
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-300.2%
Return on equity
-738.8%
Return on invested capital
-1,164.7%
Return on capital employed
-416.3%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

COEP stock price

How has the Coeptis Therapeutics Holdings stock price performed over time
Intraday
1.26%
1 week
-5.13%
1 month
2.98%
1 year
-73.94%
YTD
-52.8%
QTD
24.41%

Financial performance

How have Coeptis Therapeutics Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$21.49M
Net income
-$21.27M
Gross margin
N/A
Net margin
N/A
COEP's net income is up by 43% YoY but it is down by 4% from the previous quarter
Coeptis Therapeutics Holdings's operating income has increased by 37% YoY

Growth

What is Coeptis Therapeutics Holdings's growth rate over time

Valuation

What is Coeptis Therapeutics Holdings stock price valuation
P/E
N/A
P/B
2.93
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 68% YoY but it has decreased by 9% QoQ
The stock's price to book (P/B) is 82% less than its last 4 quarters average of 16.1
The equity is down by 3.1% year-on-year

Efficiency

How efficient is Coeptis Therapeutics Holdings business performance
Coeptis Therapeutics Holdings's return on invested capital has shrunk by 55% YoY but it has increased by 8% QoQ
COEP's return on assets is up by 41% year-on-year but it is down by 3.4% since the previous quarter
The company's return on equity rose by 33% YoY but it fell by 5% QoQ

Dividends

What is COEP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for COEP.

Financial health

How did Coeptis Therapeutics Holdings financials performed over time
The total assets is 115% greater than the total liabilities
The total liabilities is up by 35% since the previous quarter and by 9% year-on-year
The total assets has increased by 13% since the previous quarter
Coeptis Therapeutics Holdings's debt is 72% less than its equity
Coeptis Therapeutics Holdings's debt has decreased by 40% YoY and by 9% from the previous quarter
COEP's debt to equity is down by 39% year-on-year and by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.